Cogent Biosciences

About Cogent Biosciences

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. The company’s lead program, bezuclastinib, targets exon 17 mutations in the KIT receptor tyrosine kinase, which are associated with conditions such as Systemic Mastocytosis and gastrointestinal stromal tumors (GIST).

Career Opportunities

Cogent Biosciences offers a dynamic working environment that fosters professional growth and development. Employees have the opportunity to contribute to groundbreaking research and make a significant impact in the field of biotechnology.

• Collaborative work culture
• Opportunities for professional development
• Engagement in innovative research projects